(Press-News.org) An analysis of policy documents from Medicaid programs, suggests that current policies to manage conflicts of interest (COIs) of members of Medicaid drug selection committees are not transparent and vary widely, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
It is important to manage COI for formulary drug selections or reimbursement to ensure that products are selected based on evidence and with minimal bias and to protect against pharmaceutical industry influence, according to the study background.
In an analysis, Nicole Yvonne Nguyen, Pharm.D., and Lisa Bero, Ph.D., of the University of California, San Francisco, describe the content of the Medicaid drug selection committees' COI policies for the United States and the District of Columbia, categorize policies and identify the components of a strong policy. They searched official Medicaid websites and contacted Medicaid staff to identify drug selection committee COI policies for all states with Medicaid Preferred Drug Lists (47 states and the District of Columbia). They obtained policy documents for 27 of the programs (56 percent) – 14 from websites and 13 by contacting Medicaid officials.
"We found high variability in COI policies, lack of public availability and inconsistent enforcement and management of COI among states," according to the study.
According to the results, the most common management strategy was disclosure of COI in 67 percent of policies (18 of 27) and self-recusal in 52 percent of policies (14 of 27), while only 15 percent of policies (4 of 27) ban certain relationships with industry.
"Current policies to manage COIs on Medicaid drug selection committees are not transparent and vary widely in content, suggesting that some policies may not adequately protect against COIs," the study concludes. "Our findings show the need for a model COI policy for drug selection committees that can be adapted for individual states. A model policy should (1) be publically accessible (2) be comprehensive and provide explicit parameters for disclosure (3) be equally applicable to all committee members (4) include management strategies beyond disclosure and (5) indicate a responsible party for review of COI and enforcement of policies."
(JAMA Intern Med. Published online February 11, 2013. doi:10.1001/jamainternmed.2013.2522. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Managing Potential Conflicts of Interest in Medicaid Drug Selection Committees
In a related commentary, Nirav Shah, M.D., M.P.H., Commissioner of the New York State Health Department, Albany, writes: "Pharmacy and therapeutics (P & T) committee members determine the drugs available for particular indications in a hospital, health care plan or system based on the members' view of the efficacy, safety and relative cost of particular medications."
"While the primary goals of P & T committees for hospitals, self-funded employer-sponsored plans, commercial insurers and state Medicaid programs are the same, the large scope, use of public funds and the vulnerability of the population served, all make the decisions by Medicaid P & T committees particularly important," Shah continues.
"More frequent disclosure requirements, for example, may be much harder to implement relative to requiring more complete disclosure upfront, and may not add value. And burdensome disclosure requirements may discourage highly qualified candidates from serving on unpaid advisory committees, which has been our experience in New York State," Shah concludes. "Therefore, finding the right balance of disclosure and transparency, relative to other means of managing potential COIs, is paramount."
(JAMA Intern Med. Published online February 11, 2013. doi:10.1001/jamainternmed.2013.4184. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
### END
Study examines Medicaid drug selection committees, potential conflicts of interest
2013-02-12
ELSE PRESS RELEASES FROM THIS DATE:
Stage at diagnosis only partly explains wide international variation in lung cancer survival
2013-02-12
Stage at diagnosis only partly explains the wide variation in lung cancer survival rates among different developed countries, indicates a large study of nearly 60,000 patients, published online in Thorax.
Other factors, such as treatment, are also likely to have a key role, say the authors.
Stage at diagnosis has often been suggested as one of the primary reasons why lung cancer survival is low in certain countries, such the UK, on the grounds that patients go to see their doctors too late for treatment to be effective.
The authors collected information on more ...
Yearly rise in emergency admissions for kids in England since 2003
2013-02-12
The number of children admitted to hospital as emergencies has steadily increased every year since 2003, with the largest rises seen among the under 5s, indicates research published online in the Archives of Disease in Childhood.
Common infections account for much of this rise, say the authors, who suggest this indicates a "systematic failure in the NHS" to assess children with acute illness that could be better managed by family doctors, out of hours services, and the telephone advice service NHS Direct rather than hospitals.
The authors base their findings on hospital ...
TB infection rates set to 'turn clock back to 1930s'
2013-02-12
During the 1930s, dedicated sanitaria and invasive surgery were commonly prescribed for those with the infection - usually caused by Mycobacterium tuberculosis, which the editors describe as "the most successful human pathogen of all time."
TB often lies dormant with no symptoms, but in a proportion of cases, becomes active, predominantly attacking the lungs. But it can also affect the bones and nervous system, and if left untreated can be fatal.
The infection is developing increasing resistance around the world to the powerful drugs currently used to treat it.
"Whatever ...
Computerized 'Rosetta Stone' reconstructs ancient languages
2013-02-12
University of British Columbia and Berkeley researchers have used a sophisticated new computer system to quickly reconstruct protolanguages – the rudimentary ancient tongues from which modern languages evolved.
The results, which are 85 per cent accurate when compared to the painstaking manual reconstructions performed by linguists, will be published next week in the Proceedings of the National Academy of Sciences.
"We're hopeful our tool will revolutionize historical linguistics much the same way that statistical analysis and computer power revolutionized the study ...
Unchecked antibiotic use in animals may affect global human health
2013-02-12
EAST LANSING, Mich. — The increasing production and use of antibiotics, about half of which is used in animal production, is mirrored by the growing number of antibiotic resistance genes, or ARGs, effectively reducing antibiotics' ability to fend off diseases – in animals and humans.
A study in the current issue of the Proceedings of the National Academy of Sciences shows that China – the world's largest producer and consumer of antibiotics – and many other countries don't monitor the powerful medicine's usage or impact on the environment.
On Chinese commercial pig ...
Potential treatment prevents damage from prolonged seizures
2013-02-12
A new type of prophylactic treatment for brain injury following prolonged epileptic seizures has been developed by Emory University School of Medicine investigators.
Status epilepticus, a persistent seizure lasting longer than 30 minutes [check this, some people say FIVE], is potentially life-threatening and leads to around 55,000 deaths each year in the United States. It can be caused by stroke, brain tumor or infection as well as inadequate control of epilepsy. Physicians or paramedics now treat status epilepticus by administering an anticonvulsant or general anesthesia, ...
Isotopic data show farming arrived in Europe with migrants
2013-02-12
MADISON – For decades, archaeologists have debated how farming spread to Stone Age Europe, setting the stage for the rise of Western civilization.
Now, new data gleaned from the teeth of prehistoric farmers and the hunter-gatherers with whom they briefly overlapped shows that agriculture was introduced to Central Europe from the Near East by colonizers who brought farming technology with them.
"One of the big questions in European archaeology has been whether farming was brought or borrowed from the Near East," says T. Douglas Price, a University of Wisconsin-Madison ...
Sunlight stimulates release of climate-warming gas from melting Arctic permafrost
2013-02-12
ANN ARBOR — Ancient carbon trapped in Arctic permafrost is extremely sensitive to sunlight and, if exposed to the surface when long-frozen soils melt and collapse, can release climate-warming carbon dioxide gas into the atmosphere much faster than previously thought.
University of Michigan ecologist and aquatic biogeochemist George Kling and his colleagues studied places in Arctic Alaska where permafrost is melting and is causing the overlying land surface to collapse, forming erosional holes and landslides and exposing long-buried soils to sunlight.
They found that ...
Chemistry trick kills climate controversy
2013-02-12
Volcanoes are well known for cooling the climate. But just how much and when has been a bone of contention among historians, glaciologists and archeologists. Now a team of atmosphere chemists, from the Tokyo Institute of Technology and the University of Copenhagen, has come up with a way to say for sure which historic episodes of global cooling were caused by volcanic eruptions.
The answer lies in patterns of isotopes found in ancient volcanic sulfur trapped in ice core, patterns due to stratospheric photochemistry. Their mechanism is published in the highly recognized ...
Vascular brain injury greater risk factor than amyloid plaques in cognitive aging
2013-02-12
Vascular brain injury from conditions such as high blood pressure and stroke are greater risk factors for cognitive impairment among non-demented older people than is the deposition of the amyloid plaques in the brain that long have been implicated in conditions such as Alzheimer's disease, a study by researchers at the Alzheimer's Disease Research Center at UC Davis has found.
Published online early today in JAMA Neurology (formerly Archives of Neurology), the study found that vascular brain injury had by far the greatest influence across a range of cognitive domains, ...